Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 34, 3289-3295, December 1, 1974]
© 1974 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alexandrov, K.
Right arrow Articles by Frayssinet, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alexandrov, K.
Right arrow Articles by Frayssinet, C.

Microsome-dependent Binding of Benzo(a)pyrene and Aflatoxin B1 to DNA, and Benzo(a)pyrene Binding to Aflatoxin-conjugated DNA1

Kroum Alexandrov and Charles Frayssinet

Institut de Recherches Scientifiques sur le Cancer, Boîte Postale 8, 94800 Villejuif, France

Aflatoxin B1-conjugated DNA and benzo(a)pyrene (BP)-conjugated DNA (the DNA complexes formed with the active forms of these carcinogens) were isolated after incubation in vitro with liver microsomes from control, phenobarbital, methylcholanthrene, and phenobarbital plus methycholanthrene-treated rats and the reduced nicotinamide adenine dinucleotide phosphate-generating system. A DNA complex containing both carcinogens was then obtained by subsequent fixation of BP to the aflatoxin B1-conjugated DNA. Aryl hydrocarbon hydroxylase, which had levels of activity that varied with the different microsomal systems, was found to be highly specific in the activation of the two carcinogens to forms that bind to DNA. Depending on the microsomal system, BP binding to DNA increased from 2 to 6 times, but increased only 2 times for aflatoxin binding to DNA. 7,8-Benzoflavone caused an 80% inhibition of BP binding to DNA with methylcholanthrene microsomes and phenobarbital plus methylcholanthrene microsomes, but only 20 and 0%, respectively, with aflatoxin B1. However, with control and phenobarbital microsomes, a 30 to 50% increase in the binding level of aflatoxin B1 to DNA was obtained, while with BP the binding decreased 32% with these microsomes.

The fixation of ethyl acetate-soluble metabolites of BP was inhibited up to 70% with the aflatoxin B1- and aflatoxin G1-conjugated DNA's, but not with DNA's conjugated with aflatoxin B2, B2a, G2, and M1. The inhibitory effect on the binding of these metabolites was no longer observed after treatment of the aflatoxin B1- and aflatoxin G1-conjugated DNA's with CHCl3. The in vitro studies on the binding of aflatoxin and BP to DNA by these methods do not give evidence of common binding sites on the DNA molecule for the two carcinogens.

1 This work was supported in part by the Service d'Exploitation Industrielle des Tabacs et Allumettes (S.E.I.T.A.), Paris, France.

Received 2/11/74. Accepted 7/ 8/74.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1974 by the American Association for Cancer Research.